tiprankstipranks

Hannah Valantine Insider Profile

4 Followers
Hannah Valantine, Director at Pacific Biosciences, holds 22.82K shares in Pacific Biosciences (Ticker: PACB), holds 37.46K shares in CareDx (Ticker: CDNA), holds 5.20K shares in BridgeBio Pharma (Ticker: BBIO).
tipranks
Hannah Valantine

Hannah Valantine
Pacific Biosciences (PACB)
Director

Ranked #76,857 out of 97,997 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-38.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$775K
76.88%
18.18%
4.95%
A breakdown of Hannah Valantine's holdings

Insider Roles

CareDx
(CDNA)
Director
BridgeBio Pharma
(BBIO)
Director
Pacific Biosciences
(PACB)
Director
Roles that Hannah Valantine holds in companies

Most Profitable Insider Trade

Stock:
BridgeBio Pharma
(BBIO)
Rating:Informative Buy
Date:Feb 13, 2024 - Today
Return:-19.20%
The most profitable trade made by Hannah Valantine

Hannah Valantine's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Pacific Biosciences
Jun 20, 2024
Director
Uninformative Buy
$38.34K
CareDx
Jun 18, 2024
Director
Uninformative Buy
$596.00K
BridgeBio Pharma
Feb 20, 2024
Director
Uninformative Buy
24.63K
$140.94K
List of latest transactions for each holding click on a transaction to see Hannah Valantine's performance on stock

Hannah Valantine insider profile FAQ

What is the percentage of profitable transactions made by Hannah Valantine?
The percentage of profitable transactions made by Hannah Valantine is 0%.
    What is the average return per transaction made by Hannah Valantine?
    The average return per transaction made by Hannah Valantine is -38.70%.
      What stocks does Hannah Valantine hold?
      Hannah Valantine holds: PACB, CDNA, BBIO stocks.
        What was Hannah Valantine’s latest transaction?
        Hannah Valantine latest transaction was an Uninformative Buy of ―.
          What was Hannah Valantine's most profitable transaction?
          Hannah Valantine’s most profitable transaction was an Informative Buy of BBIO stock on February 13, 2024. The return on the trade was -19.20%.
            What is Hannah Valantine's role in Pacific Biosciences?
            Hannah Valantine's role in Pacific Biosciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.